ID   HMOX2_HUMAN             Reviewed;         316 AA.
AC   P30519; A8MT35; D3DUD5; I3L430; O60605;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 2.
DT   10-MAY-2017, entry version 173.
DE   RecName: Full=Heme oxygenase 2;
DE            Short=HO-2;
DE            EC=1.14.14.18 {ECO:0000250|UniProtKB:O48782};
GN   Name=HMOX2; Synonyms=HO2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=7890772; DOI=10.1074/jbc.270.11.6345;
RA   Ishikawa K.;
RT   "Heme oxygenase-2. Properties of the heme complex of the purified
RT   tryptic fragment of recombinant human heme oxygenase-2.";
RL   J. Biol. Chem. 270:6345-6350(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=1575508; DOI=10.1016/0003-9861(92)90481-B;
RA   McCoubrey W.K. Jr., Ewing J.F., Maines M.D.;
RT   "Human heme oxygenase-2: characterization and expression of a full-
RT   length cDNA and evidence suggesting that the two HO-2 transcripts may
RT   differ by choice of polyadenylation signal.";
RL   Arch. Biochem. Biophys. 295:13-20(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLN-137 AND LEU-146.
RG   NIEHS SNPs program;
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-148 (ISOFORM 2).
RA   Hillier L., Clark N., Dubuque T., Elliston K., Hawkins M., Holman M.,
RA   Hultman M., Kucaba T., Le M., Lennon G., Marra M., Parsons J.,
RA   Rifkin L., Rohlfing T., Soares M., Tan F., Trevaskis E., Waterston R.,
RA   Williamson A., Wohldmann P., Wilson R.;
RT   "The WashU-Merck EST project.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   PROTEIN SEQUENCE OF 2-17; 30-38; 48-59; 138-168; 206-214 AND 219-246,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma, and Ovarian carcinoma;
RA   Bienvenut W.V., Bilsland A.E., Keith W.N.;
RL   Submitted (JAN-2010) to UniProtKB.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 10-166.
RC   TISSUE=Intestine;
RA   Follett J., Ahn J.-Y.;
RL   Submitted (FEB-1998) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 1-264, AND HEME-BINDING SITE.
RX   PubMed=17965015; DOI=10.1074/jbc.M707396200;
RA   Bianchetti C.M., Yi L., Ragsdale S.W., Phillips G.N. Jr.;
RT   "Comparison of apo- and heme-bound crystal structures of a truncated
RT   human heme oxygenase-2.";
RL   J. Biol. Chem. 282:37624-37631(2007).
CC   -!- FUNCTION: Heme oxygenase cleaves the heme ring at the alpha
CC       methene bridge to form biliverdin. Biliverdin is subsequently
CC       converted to bilirubin by biliverdin reductase. Under
CC       physiological conditions, the activity of heme oxygenase is
CC       highest in the spleen, where senescent erythrocytes are
CC       sequestrated and destroyed. Heme oxygenase 2 could be implicated
CC       in the production of carbon monoxide in brain where it could act
CC       as a neurotransmitter.
CC   -!- CATALYTIC ACTIVITY: Protoheme + 3 [reduced NADPH--hemoprotein
CC       reductase] + 3 O(2) = biliverdin + Fe(2+) + CO + 3 [oxidized
CC       NADPH--hemoprotein reductase] + 3 H(2)O.
CC       {ECO:0000250|UniProtKB:O48782}.
CC   -!- SUBCELLULAR LOCATION: Microsome. Endoplasmic reticulum.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P30519-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P30519-2; Sequence=VSP_055031;
CC   -!- INDUCTION: Heme oxygenase 2 activity is non-inducible.
CC   -!- SIMILARITY: Belongs to the heme oxygenase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=W38932; Type=Frameshift; Positions=82; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/hmox2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D21243; BAA04789.1; -; mRNA.
DR   EMBL; S34389; AAB22110.2; -; mRNA.
DR   EMBL; BT019788; AAV38591.1; -; mRNA.
DR   EMBL; AY771350; AAV28730.1; -; Genomic_DNA.
DR   EMBL; AC007606; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471112; EAW85299.1; -; Genomic_DNA.
DR   EMBL; CH471112; EAW85300.1; -; Genomic_DNA.
DR   EMBL; BC002396; AAH02396.1; -; mRNA.
DR   EMBL; W38932; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AF051306; AAC05297.1; -; mRNA.
DR   CCDS; CCDS10517.1; -. [P30519-1]
DR   CCDS; CCDS66931.1; -. [P30519-2]
DR   PIR; I60119; I60119.
DR   PIR; S21700; S21700.
DR   RefSeq; NP_001120676.1; NM_001127204.1. [P30519-1]
DR   RefSeq; NP_001120677.1; NM_001127205.1. [P30519-1]
DR   RefSeq; NP_001120678.1; NM_001127206.2. [P30519-1]
DR   RefSeq; NP_001273196.1; NM_001286267.1.
DR   RefSeq; NP_001273197.1; NM_001286268.1. [P30519-1]
DR   RefSeq; NP_001273198.1; NM_001286269.1. [P30519-1]
DR   RefSeq; NP_001273199.1; NM_001286270.1. [P30519-1]
DR   RefSeq; NP_001273200.1; NM_001286271.1. [P30519-2]
DR   RefSeq; NP_002125.3; NM_002134.3. [P30519-1]
DR   RefSeq; XP_016878685.1; XM_017023196.1. [P30519-1]
DR   RefSeq; XP_016878686.1; XM_017023197.1. [P30519-1]
DR   UniGene; Hs.284279; -.
DR   PDB; 2Q32; X-ray; 2.40 A; A/B=1-264.
DR   PDB; 2QPP; X-ray; 2.61 A; A/B=1-264.
DR   PDB; 2RGZ; X-ray; 2.61 A; A/B=1-264.
DR   PDB; 4WMH; X-ray; 2.50 A; A=31-237.
DR   PDB; 5UC8; X-ray; 2.00 A; A/B/C/D=30-242.
DR   PDB; 5UC9; X-ray; 1.90 A; A/B/C/D=30-242.
DR   PDB; 5UCA; X-ray; 2.12 A; A/B/C/D=30-242.
DR   PDBsum; 2Q32; -.
DR   PDBsum; 2QPP; -.
DR   PDBsum; 2RGZ; -.
DR   PDBsum; 4WMH; -.
DR   PDBsum; 5UC8; -.
DR   PDBsum; 5UC9; -.
DR   PDBsum; 5UCA; -.
DR   ProteinModelPortal; P30519; -.
DR   SMR; P30519; -.
DR   BioGrid; 109406; 53.
DR   DIP; DIP-53564N; -.
DR   IntAct; P30519; 45.
DR   MINT; MINT-1384587; -.
DR   STRING; 9606.ENSP00000219700; -.
DR   ChEMBL; CHEMBL2546; -.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB04912; Stannsoporfin.
DR   iPTMnet; P30519; -.
DR   PhosphoSitePlus; P30519; -.
DR   SwissPalm; P30519; -.
DR   BioMuta; HMOX2; -.
DR   DMDM; 1170328; -.
DR   EPD; P30519; -.
DR   MaxQB; P30519; -.
DR   PaxDb; P30519; -.
DR   PeptideAtlas; P30519; -.
DR   PRIDE; P30519; -.
DR   DNASU; 3163; -.
DR   Ensembl; ENST00000219700; ENSP00000219700; ENSG00000103415. [P30519-1]
DR   Ensembl; ENST00000398595; ENSP00000381595; ENSG00000103415. [P30519-1]
DR   Ensembl; ENST00000406590; ENSP00000385100; ENSG00000103415. [P30519-1]
DR   Ensembl; ENST00000414777; ENSP00000391637; ENSG00000103415. [P30519-1]
DR   Ensembl; ENST00000458134; ENSP00000394103; ENSG00000103415. [P30519-1]
DR   Ensembl; ENST00000570646; ENSP00000459214; ENSG00000103415. [P30519-1]
DR   Ensembl; ENST00000575120; ENSP00000460926; ENSG00000103415. [P30519-2]
DR   Ensembl; ENST00000612525; ENSP00000481295; ENSG00000277424. [P30519-1]
DR   Ensembl; ENST00000615778; ENSP00000484422; ENSG00000277424. [P30519-1]
DR   Ensembl; ENST00000619528; ENSP00000484423; ENSG00000103415. [P30519-1]
DR   Ensembl; ENST00000619913; ENSP00000484467; ENSG00000103415. [P30519-1]
DR   Ensembl; ENST00000620445; ENSP00000478785; ENSG00000277424. [P30519-1]
DR   Ensembl; ENST00000621065; ENSP00000481811; ENSG00000277424. [P30519-1]
DR   Ensembl; ENST00000622146; ENSP00000483319; ENSG00000277424. [P30519-1]
DR   Ensembl; ENST00000631540; ENSP00000487673; ENSG00000277424. [P30519-1]
DR   Ensembl; ENST00000631677; ENSP00000488579; ENSG00000277424. [P30519-1]
DR   Ensembl; ENST00000632458; ENSP00000488880; ENSG00000277424. [P30519-1]
DR   Ensembl; ENST00000633319; ENSP00000488769; ENSG00000277424. [P30519-2]
DR   GeneID; 3163; -.
DR   KEGG; hsa:3163; -.
DR   UCSC; uc002cwq.5; human. [P30519-1]
DR   CTD; 3163; -.
DR   DisGeNET; 3163; -.
DR   GeneCards; HMOX2; -.
DR   HGNC; HGNC:5014; HMOX2.
DR   HPA; CAB025464; -.
DR   HPA; HPA040611; -.
DR   MIM; 141251; gene.
DR   neXtProt; NX_P30519; -.
DR   OpenTargets; ENSG00000103415; -.
DR   PharmGKB; PA29342; -.
DR   eggNOG; KOG4480; Eukaryota.
DR   eggNOG; COG5398; LUCA.
DR   GeneTree; ENSGT00390000017673; -.
DR   HOGENOM; HOG000233221; -.
DR   HOVERGEN; HBG005982; -.
DR   InParanoid; P30519; -.
DR   KO; K00510; -.
DR   PhylomeDB; P30519; -.
DR   TreeFam; TF314786; -.
DR   BRENDA; 1.14.99.3; 2681.
DR   Reactome; R-HSA-189483; Heme degradation.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-917937; Iron uptake and transport.
DR   SIGNOR; P30519; -.
DR   ChiTaRS; HMOX2; human.
DR   EvolutionaryTrace; P30519; -.
DR   GeneWiki; HMOX2; -.
DR   GenomeRNAi; 3163; -.
DR   PMAP-CutDB; P30519; -.
DR   PRO; PR:P30519; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000103415; -.
DR   CleanEx; HS_HMOX2; -.
DR   ExpressionAtlas; P30519; baseline and differential.
DR   Genevisible; P30519; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0020037; F:heme binding; IBA:GO_Central.
DR   GO; GO:0004392; F:heme oxygenase (decyclizing) activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome.
DR   GO; GO:0042167; P:heme catabolic process; IBA:GO_Central.
DR   GO; GO:0006788; P:heme oxidation; IBA:GO_Central.
DR   GO; GO:0055072; P:iron ion homeostasis; IBA:GO_Central.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0001666; P:response to hypoxia; IDA:UniProtKB.
DR   GO; GO:0006979; P:response to oxidative stress; IBA:GO_Central.
DR   CDD; cd00232; HemeO; 1.
DR   Gene3D; 1.20.910.10; -; 1.
DR   InterPro; IPR002051; Haem_Oase.
DR   InterPro; IPR016053; Haem_Oase-like.
DR   InterPro; IPR016084; Haem_Oase-like_multi-hlx.
DR   InterPro; IPR018207; Haem_oxygenase_CS.
DR   PANTHER; PTHR10720; PTHR10720; 1.
DR   Pfam; PF01126; Heme_oxygenase; 1.
DR   PIRSF; PIRSF000343; Haem_Oase; 1.
DR   PRINTS; PR00088; HAEMOXYGNASE.
DR   SUPFAM; SSF48613; SSF48613; 1.
DR   PROSITE; PS00593; HEME_OXYGENASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Endoplasmic reticulum; Heme; Iron;
KW   Metal-binding; Microsome; Oxidoreductase; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|Ref.9}.
FT   CHAIN         2    316       Heme oxygenase 2.
FT                                /FTId=PRO_0000209691.
FT   REPEAT      264    269       HRM 1.
FT   REPEAT      281    286       HRM 2.
FT   METAL        45     45       Iron (heme axial ligand).
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|Ref.9}.
FT   MOD_RES       2      2       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     29       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.8}.
FT                                /FTId=VSP_055031.
FT   VARIANT     137    137       R -> Q (in dbSNP:rs17884623).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_021067.
FT   VARIANT     146    146       P -> L (in dbSNP:rs17880805).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_021068.
FT   CONFLICT    107    107       E -> T (in Ref. 8; W38932).
FT                                {ECO:0000305}.
FT   CONFLICT    165    166       QV -> KC (in Ref. 10; AAC05297).
FT                                {ECO:0000305}.
FT   CONFLICT    222    222       Missing (in Ref. 2; AAB22110).
FT                                {ECO:0000305}.
FT   CONFLICT    276    276       Missing (in Ref. 2; AAB22110).
FT                                {ECO:0000305}.
FT   CONFLICT    281    288       SCPFRTAM -> LSLPTSY (in Ref. 2;
FT                                AAB22110). {ECO:0000305}.
FT   HELIX        33     49       {ECO:0000244|PDB:5UC9}.
FT   HELIX        52     58       {ECO:0000244|PDB:5UC9}.
FT   HELIX        64     87       {ECO:0000244|PDB:5UC9}.
FT   TURN         88     90       {ECO:0000244|PDB:5UC9}.
FT   TURN         92     94       {ECO:0000244|PDB:5UC9}.
FT   HELIX        95     97       {ECO:0000244|PDB:5UC9}.
FT   HELIX       100    103       {ECO:0000244|PDB:5UC9}.
FT   HELIX       106    117       {ECO:0000244|PDB:5UC9}.
FT   HELIX       121    124       {ECO:0000244|PDB:5UC9}.
FT   HELIX       129    144       {ECO:0000244|PDB:5UC9}.
FT   HELIX       146    148       {ECO:0000244|PDB:5UC9}.
FT   HELIX       149    175       {ECO:0000244|PDB:5UC9}.
FT   HELIX       185    187       {ECO:0000244|PDB:5UC9}.
FT   HELIX       195    207       {ECO:0000244|PDB:5UC9}.
FT   HELIX       213    238       {ECO:0000244|PDB:5UC9}.
FT   TURN        243    247       {ECO:0000244|PDB:2Q32}.
SQ   SEQUENCE   316 AA;  36033 MW;  BF4B6A341F1A81AC CRC64;
     MSAEVETSEG VDESEKKNSG ALEKENQMRM ADLSELLKEG TKEAHDRAEN TQFVKDFLKG
     NIKKELFKLA TTALYFTYSA LEEEMERNKD HPAFAPLYFP MELHRKEALT KDMEYFFGEN
     WEEQVQCPKA AQKYVERIHY IGQNEPELLV AHAYTRYMGD LSGGQVLKKV AQRALKLPST
     GEGTQFYLFE NVDNAQQFKQ LYRARMNALD LNMKTKERIV EEANKAFEYN MQIFNELDQA
     GSTLARETLE DGFPVHDGKG DMRKCPFYAA EQDKGALEGS SCPFRTAMAV LRKPSLQFIL
     AAGVALAAGL LAWYYM
//
